Challenges and Successes of Distributing Birth Kits with Misoprostol to Reduce Maternal Mortality in Rural Tanzania
Abstract
Full Text:
PDFReferences
Ministry of Health, Community Development, Gender,
Elderly and Children (Mo-HCDGEC) [Tanzania Mainland], Ministry of Health (MoH) [Zanzibar], National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OCGS), and ICF. 2016. Tanzania Demographic and Health Survey and Malaria Indicator Survey (TDHS-MIS) 2015-
Dar es Salaam, Tanzania, and Rockville,
Maryland, USA:MoHCDGEC, MoH, NBS, OCGS,
and ICF.
Crowe S, Utley M, Costello A and Page C. How many
births in sub-Saharan Africa and South Asia will not
be attended by a skilled birth attendant between
and 2015? BMC Pregnancy Childbirth 2012;
:4.
Webber G, Chirangi B and Magatti N. Community
member and policy maker priorities in improving
maternal health in rural Tanzania, Int J Gynecol
Obstet 2018; 1-5. DOI: 10.1002/ijgo.12435.
Bohren M, Hunter E, Munthe-Kaas HM, Souza JP,
Vogel JP and Gulmezoglu AM. Facilitators and
barriers to facility-based delivery in low- and middle-income countries: a qualitative evidence synthesis. Reprod Health 2014; 11:71. http://www.reproductive-healthjournal.
com/content/11/1/71
Smith JM, Gubin R, Holston MM, Fullerton J and Prata
N. Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date. BMC Pregnancy Childbirth 2013; 13:44.
G lmezoglu A, Forna F, Villar J and Hofmeyr GJ.
Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2007, Issue 3. Art. No.: CD000494. DOI: 10.1002/14651858.CD000494.pub3.
Sheldon WR, Blum J, Durocher J and Winikoff B.
Misoprostol for the prevention and treatment of postpartum hemorrhage. Expert Opinion on Investigational Drugs 2012; 21(2):235-250.
WHO recommendations for the prevention and treatment
of postpartum haemorrhage (2012) . Available
online at http://apps.who.int/iris/bitstream/handle/10665/754
/9789241548502_eng.pdf?sequence=1 Accessed
on May 12, 2018.
FIGO Safe Motherhood and Newborn Health (SMNH)
Committee, FIGO Guidelines, Prevention and
treatment of post-partum hemorrhage in low resource settings, Int J GynecolObstet 2012; 117:108–118.
Tanzania Food and Drug Authority, Approval of
Misoprostol for PPH prevention. Accessed on July
, 2018 at https://www.tfda.go.tz/index/sites/default/files/13.p
df
Prata N, Mbaruku G, Grossman AA, Holston M and
Hsieh K. Community-Based Availability of Misoprostol: Is It Safe? Afr J Reprod Health 2009; 13(2): 117-128.
VSI and partners, Prevention of Postpartum Hemorrhage
at Home Births: Misoprostol Distribution during
Antenatal Visits Final Report, February 2011.
Webber G and Chirangi B. Women's Health in Women's
Hands: A Pilot Study Assessing the Feasibility of Providing Women with Medications to Reduce Postpartum Hemorrhage and Sepsis in Rural Tanzania, Health Care Women Int 2014;
:1–13, DOI:10.1080/07399332.2014.915843
Webber G and Chirangi B. ―Please Do Not Forget
Us‖ - Views of Women, Nurses, and Traditional
Birth Attendants on Community Distribution of Medications to Prevent Postpartum Hemorrhage and Sepsis: A Qualitative Pilot Study in Rural Tanzania J Women‘s Health Care 2014; 3: 168. doi:10.4172/2167-0420.1000168
Sullivan T and Hirst J. Reducing Maternal Mortality: A
Review of Progress and Evidence-Based Strategies
to Achieve Millennium Development Goal 5.
Health Care Women Int 2011; 32: 901–916.
Hobday K, Hulme J, Belton S, Homer C and Prata N.
Community-based misoprostol for the prevention of
postpartum haemorrhage: A narrative review of the
evidence base, challenges and scale-up. Global
Public Health 2017;
http://dx.doi.org/10.1080/17441692.2017.1303743
Samnani A, Rizvi N, Ali TS and Abrejo F. Barriers or
gaps in implementation of misoprostol use of postabortion
care and post-partum hemorrhage
prevention in developing countries: a systematic
review. Reprod Health 2017; 14:139. DOI
1186/s12978-017-0383-5.
Refbacks
- There are currently no refbacks.




